Virtus ETF Advisers’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,214
| Closed | -$70.6K | – | 363 |
|
|
2024
Q4 | $70.6K | Sell |
4,214
-5,071
| -55% | -$84.9K | 0.03% | 374 |
|
|
2024
Q3 | $148K | Buy |
9,285
+169
| +2% | +$2.7K | 0.07% | 328 |
|
|
2024
Q2 | $82.3K | Buy |
+9,116
| New | +$82.3K | 0.04% | 394 |
|
|
2022
Q2 | – | Sell |
-13,969
| Closed | -$125K | – | 447 |
|
|
2022
Q1 | $125K | Sell |
13,969
-829
| -6% | -$7.42K | 0.06% | 255 |
|
|
2021
Q4 | $167K | Buy |
+14,798
| New | +$167K | 0.06% | 298 |
|